EP1326623A4 - Saururus chinensis extract for prevention and treatment of neurodegenerative disease - Google Patents

Saururus chinensis extract for prevention and treatment of neurodegenerative disease

Info

Publication number
EP1326623A4
EP1326623A4 EP01981111A EP01981111A EP1326623A4 EP 1326623 A4 EP1326623 A4 EP 1326623A4 EP 01981111 A EP01981111 A EP 01981111A EP 01981111 A EP01981111 A EP 01981111A EP 1326623 A4 EP1326623 A4 EP 1326623A4
Authority
EP
European Patent Office
Prior art keywords
prevention
treatment
chinensis extract
neurodegenerative disease
saururus chinensis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP01981111A
Other languages
German (de)
French (fr)
Other versions
EP1326623B1 (en
EP1326623A1 (en
Inventor
Young-Joong Kim
Sang-Hyun Sung
So-Ra Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elcom Bio Technology Co Ltd
Original Assignee
Elcom Bio Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR10-2000-0061687A external-priority patent/KR100446089B1/en
Priority claimed from KR10-2000-0061688A external-priority patent/KR100446090B1/en
Application filed by Elcom Bio Technology Co Ltd filed Critical Elcom Bio Technology Co Ltd
Publication of EP1326623A1 publication Critical patent/EP1326623A1/en
Publication of EP1326623A4 publication Critical patent/EP1326623A4/en
Application granted granted Critical
Publication of EP1326623B1 publication Critical patent/EP1326623B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)

Abstract

The present invention relates to Saururus chinensis extract for prevention and treatment of neurodegenerative disease and pharmaceutical preparations containing Saururs chinensis extract or an aristolactam alkaloid derivative separated therefrom.
EP01981111A 2000-10-19 2001-10-19 Saururus chinensis extract for prevention and treatment of neurodegenerative disease Expired - Lifetime EP1326623B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR2000061688 2000-10-19
KR2000061687 2000-10-19
KR10-2000-0061687A KR100446089B1 (en) 2000-10-19 2000-10-19 Saururus chinensis extract for prevention and treatment of neurodegenerative disease and pharmaceutical preparations containing the same
KR10-2000-0061688A KR100446090B1 (en) 2000-10-19 2000-10-19 Pharmaceutical preparations containing an saurolactam alkaloid derivative for prevention and treatment of neurodegenerative disease
PCT/KR2001/001766 WO2002032443A1 (en) 2000-10-19 2001-10-19 Saururus chinensis extract for prevention and treatment of neurodegenerative disease

Publications (3)

Publication Number Publication Date
EP1326623A1 EP1326623A1 (en) 2003-07-16
EP1326623A4 true EP1326623A4 (en) 2004-06-09
EP1326623B1 EP1326623B1 (en) 2007-04-25

Family

ID=26638479

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01981111A Expired - Lifetime EP1326623B1 (en) 2000-10-19 2001-10-19 Saururus chinensis extract for prevention and treatment of neurodegenerative disease

Country Status (8)

Country Link
US (1) US20030045564A1 (en)
EP (1) EP1326623B1 (en)
JP (1) JP4157767B2 (en)
CN (1) CN1245983C (en)
AT (1) ATE360431T1 (en)
AU (1) AU2002212774A1 (en)
DE (1) DE60128120T2 (en)
WO (1) WO2002032443A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080260873A1 (en) * 2007-04-23 2008-10-23 Fancl Corporation Agent for prevention or improvement of neuropathy comprising pre-germinated brown rice lipid fraction as an effective ingredient
KR101124350B1 (en) * 2007-10-17 2012-03-15 한국화학연구원 Phenanthrene lactam derivatives having anticancer activity, method for preparing same and pharmaceutical composition containing same
WO2018111050A1 (en) * 2016-12-15 2018-06-21 한국생명공학연구원 Pharmaceutical composition comprising phenanthrene-lactam-based compound as effective ingredient for preventing or treating dyrk-related disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619943A (en) * 1981-06-04 1986-10-28 Rao Koppaka V Neolignans of Saururus cernuus L and analogues thereof
US4782077A (en) * 1987-08-20 1988-11-01 Monoclonetics International, Inc. Taliscanin and other aristolactams for treating neurological disorders, Parkinson's disease, Alzheimer disease and impotence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4014177B2 (en) * 1997-03-10 2007-11-28 株式会社資生堂 Protease inhibitor
KR100380634B1 (en) * 2000-10-19 2003-04-26 주식회사 엘컴사이언스 Composition containing a dibenzocyclooctane lignan derivative for prevention or treatment of neurodegenerative disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619943A (en) * 1981-06-04 1986-10-28 Rao Koppaka V Neolignans of Saururus cernuus L and analogues thereof
US4782077A (en) * 1987-08-20 1988-11-01 Monoclonetics International, Inc. Taliscanin and other aristolactams for treating neurological disorders, Parkinson's disease, Alzheimer disease and impotence

Also Published As

Publication number Publication date
AU2002212774A1 (en) 2002-04-29
US20030045564A1 (en) 2003-03-06
WO2002032443A1 (en) 2002-04-25
ATE360431T1 (en) 2007-05-15
EP1326623B1 (en) 2007-04-25
JP4157767B2 (en) 2008-10-01
EP1326623A1 (en) 2003-07-16
JP2004511525A (en) 2004-04-15
DE60128120D1 (en) 2007-06-06
DE60128120T2 (en) 2008-01-10
CN1245983C (en) 2006-03-22
CN1394143A (en) 2003-01-29

Similar Documents

Publication Publication Date Title
AU3652102A (en) Compounds and their uses
IL153676A0 (en) Liposomal pharmaceutical compositions
WO2001062223A3 (en) Cosmetic preparations containing plant extracts
DE60037020D1 (en) Anilinochinazoline als protein-tyrosin-kinasehemmer
HUP0203437A3 (en) Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
BG66083B1 (en) Pharmaceutical compositions containing antibodies, and antibodies for prevention andf treatment of amyloidogenic disease
IL149525A0 (en) Use of hydroxyflavanones for masking bitter taste
EP1423107A4 (en) Fatty alcohol drug conjugates
MXPA05004247A (en) Chromones and chromone derivatives and uses thereof.
GEP20084442B (en) Compositions for the treatment of neurocerebrovascular disorders
WO2000072837A3 (en) Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
MXPA03010549A (en) Oxcarbazepine dosage forms.
MY137435A (en) Retinoid compounds (i)
MXPA04002714A (en) Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug.
AU2002226030A1 (en) Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
WO2004033448A3 (en) Isolation, purification and synthesis of procyanidin b2 and uses thereof
HK1104280A1 (en) Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
SI1390008T1 (en) Pharmaceutical and cosmetic compositions comprising phospholipid complexes of vitis vinifera and of centella asiactica
WO2001014395A3 (en) Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
EP1326623A4 (en) Saururus chinensis extract for prevention and treatment of neurodegenerative disease
ATE402158T1 (en) FLAVONOID DERIVATIVE
EP1303300A4 (en) Compositions and methods for treatment of candidiasis
PL368040A1 (en) Substituted 4-aminocyclohexanol derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020617

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040428

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 35/78 A

Ipc: 7A 61P 25/28 B

Ipc: 7A 61K 31/40 B

17Q First examination report despatched

Effective date: 20041227

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/40 20060101ALI20061019BHEP

Ipc: A61K 36/78 20060101AFI20061019BHEP

Ipc: A61P 25/28 20060101ALI20061019BHEP

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KIM, YOUNG-JOONG

Inventor name: SUNG, SANG-HYUN

Inventor name: KIM, SO-RA

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070425

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070425

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070425

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 60128120

Country of ref document: DE

Date of ref document: 20070606

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070725

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070805

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070925

ET Fr: translation filed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070425

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070425

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20080128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070726

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071031

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20071019

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071019

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071019

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071019

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070425

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20121022

Year of fee payment: 12

Ref country code: FR

Payment date: 20121113

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20121024

Year of fee payment: 12

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60128120

Country of ref document: DE

Effective date: 20140501

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20140630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20131031

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20131019

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140501